Cleared Traditional

Electronic Blood Pressure Monitor (K200716) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200716 · Shenzhen Pango Electronic Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
261d
Days
Class 2
Risk

K200716 is an FDA 510(k) clearance for the Electronic Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Pango Electronic Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 4, 2020 after a review of 261 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Pango Electronic Co., Ltd. devices

Submission Details

510(k) Number K200716 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 2020
Decision Date December 04, 2020
Days to Decision 261 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 125d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 273
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K200716.
Wrist Type Blood Pressure Monitor
K200346 · Avita Corporation · Dec 2020
Transtek Wrist Blood Pressure Monitor
K202599 · Guangdong Transtek Medical Electronics Co., Ltd. · Dec 2020
InBody
K200442 · Inbody Co., Ltd. · Dec 2020
V20, V20a, AVSM3 SNF
K200434 · Mediana Co., Ltd. · Oct 2020
Blood Pressure Monitor-Model 2005, 2006-2, 2006-2B
K201467 · Bioland Technology, Ltd. · Sep 2020
Electronic Blood Pressure Monitor
K200939 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Aug 2020